Below is an excerpt from the current vote related to the allotment performance incentives to the directors
(d) Names and category of the allottees:
Francis Harper - director and therefore related party (or nominee): 7,000,000 Incentive Options
Andrew Pardey – director and therefore related party (or nominee): 3,500,000 Incentive Options
(e) Terms of issue:
As noted in the ASX Announcement dated 22 March 2021, The Incentive Options will be exercisable at 9.86 cents
per share and expiring 3 years from date of issue and otherwise on the terms set out in Schedule 2.
I'm interested to find out what other shareholders think of this allotment of options to the directors.
In essence they are receiving a lot of shares that are excisable for < 10c within 3 yrs.
Personally I think this incentive goal Ref Resolutions 1 & 2 with exercisable options 9.86c is set way to low and that correspondingly shareholders should vote against these overly generous incentive terms.
The basis for this comment is that that the excisable SP should be set with a higher more realistic incentive goal at say 0.15c within 3 yrs which is less than double the current price of 0.85. As it stands the incentive is that the options are in the money & excisable at 9.86c or a meagre 14.8% increase. That equates to < 5% in each of the three years. IMO this is not much of an incentive as with the current drill and assay results the price objective can be easily met.
With regards to Resolution 3 the 8,000,000 shares are already 'in the money' as the shares are awarded at 7.1c ech.
At today's price of 8.5c this is a windfall motion that represents an immediate profit of $112,000.
So I ask share holders, where is the incentive for ongoing performance?
With regards to Resolution 4 - Employee Securities Incentive Plan. There is absolutely no information as to what the Plan consists of and hence voting for this item would appear to me to be sheer folly.
What do other shareholder think about these matters and how are you intending to vote?
- Forums
- ASX - By Stock
- Ann: Letter to Shareholders
Below is an excerpt from the current vote related to the...
Featured News
Add PDI (ASX) to my watchlist
|
|||||
Last
18.8¢ |
Change
0.003(1.35%) |
Mkt cap ! $440.0M |
Open | High | Low | Value | Volume |
18.5¢ | 19.0¢ | 18.3¢ | $200.6K | 1.080M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 250900 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 170851 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 243328 | 0.185 |
11 | 378558 | 0.180 |
6 | 314090 | 0.175 |
10 | 631172 | 0.170 |
10 | 297986 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 170886 | 12 |
0.195 | 295646 | 7 |
0.200 | 440110 | 8 |
0.205 | 354765 | 6 |
0.210 | 889089 | 8 |
Last trade - 15.42pm 03/07/2024 (20 minute delay) ? |
Featured News
PDI (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online